McClure JB, et al.: Evaluating an adaptive and interactive mHealth smoking cessation and medication adherence program: a randomized

Respuesta :

The solution is It was determined that the MyMAP intervention was workable and acceptable. No judgments about the program's effects on medication adherence or smoking cessation can be formed because the study was not powered for statistical significance, but the overall study results indicate that more investigation in a bigger randomized trial is necessary.

The MyMAP software was extensively utilized, as evidenced by the greater mean program log-ins by experimental participants than by control participants (10.6 vs 2.7, P.001). The majority of trial participants believed the MyMAP program may aid in the cessation of smoking (22/24, 92%), regularly used their quit-smoking medicine (17/22, 97%), and would advocate for the program to others (20/23, 87%). They also said the software was user-friendly, convenient, and sensitive to their demands. At the 5-month follow-up, the experimental arm had an abstinence rate of 36% compared to the control group's 24% (odds ratio: 1.79 [0.61-5.19], P=.42). In comparison to controls, experimental subjects utilized their varenicline on average for 46 days as opposed to 39 (P=.49). Three-quarters (25/33, 76%) of controls and more than two-thirds (22/33, 67%) of experimental participants abruptly stopped using varenicline.

What is Smoking cessation?

  • The process of giving up tobacco use is known as smoking cessation, sometimes referred to as quitting or halting.
  • Nicotine, which is addictive and can lead to dependency, is present in tobacco smoke.
  • As a result, withdrawal from nicotine frequently makes quitting difficult.

To learn more about Smoking cessation click:-

https://brainly.com/question/3021724?referrer=searchResults

#SPJ4